RESULTS OF THE APPLICATION OF MAGNETOLAZER THERAPY AND LOCAL HYPOXIA FOR PREVENTION OF ACUTE TOXICITY IN PATIENTS WITH HEAD AND NECK CANCER
Radiotherapy for head and neck cancer is accompanied by the development of acute toxicity of normal tissues. For the prevention of the development of severe acute toxicity, anti-inflammatory medication has traditionally been used. This article presents the results of our own clinical randomized trial with the use of magnetolaser therapy and hypoxic therapy to reduce the frequency and severity of acute toxicity.